These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 51913)

  • 21. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 22. [Myasthenia gravis and other neuromuscular diseases].
    Pirskanen R
    Duodecim; 1979; 95(21):1401-11. PubMed ID: 527509
    [No Abstract]   [Full Text] [Related]  

  • 23. Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission.
    Hohlfeld R
    Lab Invest; 1990 Mar; 62(3):241-3. PubMed ID: 2156108
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.
    Serra A; Ruff RL; Leigh RJ
    Ann N Y Acad Sci; 2012 Dec; 1275(1):129-35. PubMed ID: 23278588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the impaired neuromuscular transmission in myasthenia gravis].
    Kruckenberg P; Pontzen W; Sandweg R; Bauer H
    Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduced neuromuscular transmission safety factor in multiple sclerosis.
    Eisen A; Yufe R; Trop D; Campbell I
    Neurology; 1978 Jun; 28(6):598-602. PubMed ID: 206859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenic syndrome studied with single fiber electromyography.
    Schwartz MS; Stålberg E
    Arch Neurol; 1975 Dec; 32(12):815-7. PubMed ID: 173269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 31. A case of multiple sclerosis associated with defective neuromuscular transmission.
    Cendrowski W
    Acta Neurol Belg; 1975; 75(1):11-4. PubMed ID: 173125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of decremental response in decentralized muscles of a myasthenic patient.
    Fiacchino F; Crenna P; Sghirlanzoni A; Peluchetti D; Allegranza A
    Ital J Neurol Sci; 1983 Sep; 4(3):355-7. PubMed ID: 6315636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttetanic potentiation in a patient with myasthenia gravis.
    Singer P; Smith L; Ziegler DK; Festoff BW
    Neurology; 1981 Oct; 31(10):1345-7. PubMed ID: 6287354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient neonatal myasthenia. Clinical and electromyographic studies.
    Wise GA; McQuillen MP
    Arch Neurol; 1970 Jun; 22(6):556-65. PubMed ID: 4314803
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic aspects of myasthenia gravis].
    Friedli WG
    Schweiz Rundsch Med Prax; 1989 Sep; 78(38):1037-44. PubMed ID: 2552554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Behavioral of evoked potentials in repeated stimulation of the facial nerve and electromyographic diagnosis of myasthenia gravis].
    Bassi S; Crespi V; Passerini D; Smirne S
    Riv Neurol; 1975; 45(1):60-3. PubMed ID: 167419
    [No Abstract]   [Full Text] [Related]  

  • 38. Further electrophysiological studies of neuromuscular transmission in an animal model of myasthenia gravis.
    Kim YI; Sanders DB
    Exp Neurol; 1981 Jul; 73(1):1-19. PubMed ID: 6265267
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple sclerosis associated with defects in neuromuscular transmission.
    Patten BM; Hart A; Lovelace R
    J Neurol Neurosurg Psychiatry; 1972 Jun; 35(3):385-94. PubMed ID: 4338448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple sclerosis associated with myasthenia].
    Shutov AA; Tiutikova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):374-6. PubMed ID: 3033958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.